COCCI News
Product updates and industry trends
"Adding value" is an expression producers frequently
hear in today's global poultry industry "and for good
reason.
The competition is keen, the market is price-sensitive
and international trade agreements can be volatile.
Progressive poultry companies know they have to continually
raise the bar for quality and consistency to win
consumer confidence and to build brand and customer
loyalty. It is, after all, the only way to separate your poultry products from the
many others in the meat case.
It's not much different on the animal health side of the business. Sure, Schering-
Plough Animal Health Corporation is known worldwide as a leading developer
of vaccines in the poultry industry "a business we've been honing since we
shipped our first batch of vaccine in 1921.
But like you, we're not alone in this business. We have lots of competitors, some
more formidable than others. To win your trust and loyalty, we have to keep
bringing "added value" to our products.
Providing expertise and top-notch technical support is, of course, one way we try
to meet that objective. By working side-by-side with our customers, conducting
field trials, presenting new ideas at industry meetings and publishing information
in technical bulletins, scientific journals and, of course, our own CocciForum
magazine, we're committed to keeping our customers on the forefront of
coccidiosis management.
Perhaps less apparent to our customers is the work we do behind the scenes to
ensure vaccine quality and consistency. Let's face it: Virtually any company with
a fermenter and a government license can call itself a vaccine manufacturer.
However, it takes an industry leader "with its rigid guidelines for quality
assurance and control that often exceed government criteria "to deliver the
consistency and performance that you demand from a vaccine.
This is particularly important for coccidiosis vaccines, where plant QA/QC
procedures and meticulous biosecurity need to be paramount to avoid introducing
new pathogens to vaccines. Maintaining the right balance of Eimeria antigens
is also critical to producer performance and safety.
It is for these reasons that I hope you'll take time to read our Special Report on
the intricacies of coccidiosis vaccine production and the steps we've taken to
bring you "added value."
Source: CocciForum Issue No.5, Schering-Plough Animal Health.